Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry
Cancers · 22.05.2026 · 18 (11) · 1684
DOI: 10.3390/cancers18111684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 22.05.2026. Verfasst von Yuki Kawaji und 14 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Wakayama, Japan. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Pancreatic cancer (PC) should be diagnosed in its early stages. Therefore, it is necessary to identify high-risk individuals of PC.
Methods
Between 2001 and 2017, 1542 PC cases were diagnosed at two tertial care institutions. Of these, 117 cases had undergone abdominal contrast-enhanced computed tomography (CE-CT) 1–10 years before PC diagnosis and were classified as the PC group. Meanwhile, 43,102 cases underwent abdominal CE-CT for close examination of non-pancreatic diseases in the same period, of which 1170 were randomly selected. Of these, 117 cases were matched to the PC group with the propensity score and designated the non-PC group. Pancreatic volumetry was performed using the 3D image analysis system for abdominal CE-CT in both groups and various measurements were compared. In PC group, CE-CT taken 1–10 years before the onset of PC was analyzed.
Results
After propensity score matching, baseline characteristics did not significantly differ between the two groups. The whole pancreatic volume/body surface area (BSA) (p = 0.014), volume of main pancreatic duct (MPD) plus cystic lesion/BSA (p < 0.001), volume of pancreatic parenchyma/BSA (p = 0.002), ratio of cross-sectional areas (p = 0.033), and MPD diameter/BSA (p < 0.001) significantly differed between the two groups. In subgroup analysis of patients without cystic lesions, the whole pancreatic volume/BSA, volume of MPD/BSA, volume of pancreatic parenchyma/BSA, ratio of cross-sectional areas, and MPD diameter/BSA significantly differed between the two groups.
Conclusions
Pancreatic volumetry could identify patients at high risk of PC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Wakayama, Japan.
- Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, 377-2, Sayama 589-8511, Osaka, Japan.
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Aichi, Japan.
- Clinical Study Support Center, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Wakayama, Japan.
ORCID-Profile: Mamoru Takenaka, Ke Wan, Akiya Nakahata, Takashi Tamura, Yasunobu Yamashita, Masayuki Kitano
Zitieren
APA
Kawaji, Y., Yamao, K., Ashida, R., Takenaka, M., Omoto, S., Wan, K., Ishihara, T., Sugihara, Y., Morishita, H., Nakahata, A., Shishimoto, T., Tamura, T., Yamashita, Y., Itonaga, M., & Kitano, M. (2026). Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry. Cancers, 18(11), 1684. https://doi.org/10.3390/cancers18111684
Vancouver
Kawaji Y, Yamao K, Ashida R, Takenaka M, Omoto S, Wan K, et al. Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry. Cancers. 2026;18(11):1684. doi:10.3390/cancers18111684
BibTeX
@article{Kawaji2026,
author = {Kawaji, Yuki and Yamao, Kentaro and Ashida, Reiko and Takenaka, Mamoru and Omoto, Shunsuke and Wan, Ke and Ishihara, Tomokazu and Sugihara, Yuto and Morishita, Hiromu and Nakahata, Akiya and Shishimoto, Takahiro and Tamura, Takashi and Yamashita, Yasunobu and Itonaga, Masahiro and Kitano, Masayuki},
title = {Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1684},
doi = {10.3390/cancers18111684}
}
EUVIMED